InvestorsHub Logo

biodoc

06/02/15 10:54 PM

#106133 RE: edge #106132

I bought more after reviewing the incredible science behind Brilacidin and Kevetrin, Cellceutix's impressive clinical progress, and the current company valuation. Delighted I did. Brilacidin/Kevetrin. I know what I own.

This didn't hurt either:
http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pdf

Good luck.